Smith & Nephew, GB0009223206

Smith & Nephew stock heads into the open after a 0.8% dip

Published on 09/21/2026 at 05:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 18, 2026, Smith & Nephew stock finished at GBP 10.27 on the London Stock Exchange, down 0.8 percent for the day while FTSE 100 slipped about 1.5 percent. Today investors watch sector and broader index moves around the stock.

Techniker prüfen Implantate im sterilen Reinraum eines Medizintechnik-Werks
Smith & Nephew plc (ISIN GB0009223206) fertigt orthopädische Implantate in sterilen Reinraum-Anlagen mit hoher Präzision, Illustration mit AI erstellt.

Smith & Nephew stock closed at GBP 10.27 on the London Stock Exchange on September 18, 2026, down 0.8 percent from the prior close.

September 18, 2026 in numbers

Smith & Nephew plc (ISIN GB0009223206) ended the September 18, 2026 session on the London Stock Exchange at GBP 10.27 after trading between a day low of GBP 10.25 and a day high of GBP 10.28, with about 4,750,213 shares changing hands according to intraday data from Patria.cz.

The stock’s 0.8 percent decline on September 18, 2026 compared with a roughly 1.45 percent drop in the FTSE 100 index the same day, indicating a somewhat smaller loss than the broader large cap benchmark, based on index figures reported by Reuters for the United Kingdom market.

Today’s outlook

Today, Smith & Nephew enters the new session without a specific company event due on September 21, 2026 in the latest available investor information, so trading focus is likely to remain on broader market sentiment and sector dynamics around European healthcare and medical technology names.

Recent commentary highlighting Smith & Nephew’s debt management and analyst price targets in mid-September 2026, as reported by Ad-hoc-news, may continue to frame investor expectations into the open even though no new update is scheduled today.

Disclaimer...

en | GB0009223206 | SMITH & NEPHEW | boerse | 70141011 | bgmi